Search research articles
Contact Us
Filters
Showing results (11-20 of 123) with videos related to
Page
of 13
Sort By:
Journal of Clinical Hypertension (Greenwich, Conn.)
|
April 7, 2011
Relationships among insulin resistance, type 2 diabetes, essential hypertension, and cardiovascular disease: similarities and differences
Gerald M Reaven
Metabolism: Clinical and Experimental
|
June 3, 2011
Comparison of two methods using plasma triglyceride concentration as a surrogate estimate of insulin action in nondiabetic subjects: triglycerides × glucose versus triglyceride/high-density lipoprotein cholesterol
Fahim Abbasi, Gerald M Reaven
Metabolism: Clinical and Experimental
|
March 26, 2002
Relationship between fasting and day-long plasma glucose concentrations in diet-treated patients with type 2 diabetes
F Abbasi, Gerald M Reaven
Diabetes Care
|
July 3, 2008
Insulin resistance and hyperinsulinemia: you can't have one without the other
Sun H Kim, Gerald M Reaven
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research
|
May 28, 2016
Insulin clearance: an underappreciated modulator of plasma insulin concentration
Sun H Kim, Gerald M Reaven
Diabetes & Vascular Disease Research
|
November 25, 2005
The metabolic syndrome: one step forward, two steps back
Sun H Kim, Gerald M Reaven
Diabetes Care
|
November 15, 2007
Isolated impaired fasting glucose and peripheral insulin sensitivity: not a simple relationship
Sun H Kim, Gerald M Reaven
The American Journal of Clinical Nutrition
|
July 26, 2013
Cardiometabolic risk factors and obesity: does it matter whether BMI or waist circumference is the index of obesity?
Fahim Abbasi, Christine Blasey, Gerald M Reaven
Acta Diabetologica
|
February 20, 2013
Evaluation of fasting plasma insulin concentration as an estimate of insulin action in nondiabetic individuals: comparison with the homeostasis model assessment of insulin resistance (HOMA-IR)
Fahim Abbasi, QueenDenise Okeke, Gerald M Reaven
Metabolism: Clinical and Experimental
|
April 2, 2010
What is the effect of rosiglitazone treatment on insulin secretory function in insulin-resistant individuals? It depends on how you measure it
Fahim Abbasi, Cindy Lamendola, Gerald M Reaven
Page
of 13
Search research articles
Search
Showing results (11-20 of 123) with videos related to
Sort By:
Page
of 13
Journal of Clinical Hypertension (Greenwich, Conn.)
|
April 7, 2011
Relationships among insulin resistance, type 2 diabetes, essential hypertension, and cardiovascular disease: similarities and differences
Gerald M Reaven
Metabolism: Clinical and Experimental
|
June 3, 2011
Comparison of two methods using plasma triglyceride concentration as a surrogate estimate of insulin action in nondiabetic subjects: triglycerides × glucose versus triglyceride/high-density lipoprotein cholesterol
Fahim Abbasi, Gerald M Reaven
Metabolism: Clinical and Experimental
|
March 26, 2002
Relationship between fasting and day-long plasma glucose concentrations in diet-treated patients with type 2 diabetes
F Abbasi, Gerald M Reaven
Diabetes Care
|
July 3, 2008
Insulin resistance and hyperinsulinemia: you can't have one without the other
Sun H Kim, Gerald M Reaven
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research
|
May 28, 2016
Insulin clearance: an underappreciated modulator of plasma insulin concentration
Sun H Kim, Gerald M Reaven
Diabetes & Vascular Disease Research
|
November 25, 2005
The metabolic syndrome: one step forward, two steps back
Sun H Kim, Gerald M Reaven
Diabetes Care
|
November 15, 2007
Isolated impaired fasting glucose and peripheral insulin sensitivity: not a simple relationship
Sun H Kim, Gerald M Reaven
The American Journal of Clinical Nutrition
|
July 26, 2013
Cardiometabolic risk factors and obesity: does it matter whether BMI or waist circumference is the index of obesity?
Fahim Abbasi, Christine Blasey, Gerald M Reaven
Acta Diabetologica
|
February 20, 2013
Evaluation of fasting plasma insulin concentration as an estimate of insulin action in nondiabetic individuals: comparison with the homeostasis model assessment of insulin resistance (HOMA-IR)
Fahim Abbasi, QueenDenise Okeke, Gerald M Reaven
Metabolism: Clinical and Experimental
|
April 2, 2010
What is the effect of rosiglitazone treatment on insulin secretory function in insulin-resistant individuals? It depends on how you measure it
Fahim Abbasi, Cindy Lamendola, Gerald M Reaven
Page
of 13